Need Training?

Build a solid foundation in science, formulation and product development—find out more!

Most Popular in:

North America

New in North America (page 12 of 21)

Nov 20, 2007 | 12:50 PM CST

EU, FDA Work Toward Harmonization

The Transatlantic Economic Council (TEC) meeting made an important step forward in harmonization between the EU and the FDA.

Nov 01, 2007 | 10:27 AM CDT

North American Chemical Group Asks SDA for Info

The Security and Prosperity Partnership (SPP) has asked the Soap and Detergent Association (SDA) to provide the Environmental Protection Agency (EPA) with relevant chemical data.

Oct 26, 2007 | 09:15 AM CDT

California; CTFA to Host Issues Conference

The State of California and CTFA are hosting a conference to address green chemistry, air quality and implementation of the California Safe Cosmetics Act.

Oct 25, 2007 | 09:17 AM CDT

Diacetyl in the News Again

The Associated Press (AP) has posted a story on diacetyl issues in California titled “California struggles with its own diacetyl problem.”

Oct 23, 2007 | 04:50 PM CDT

CTFA Regulatory Science Summit Covers All Bases

More than 150 industry experts and government scientists came together for the first ever Cosmetic, Toiletry and Fragrance Association (CTFA) Regulatory Science Summit.

Oct 22, 2007 | 09:57 AM CDT

CIR Reviews Basic Violet 3 and Licorice Extract

At its Sept. 24-25 meeting, The Cosmetic Ingredient Review (CIR) expert panel has requested more data on basic violet 3 and licorice extract.

Oct 12, 2007 | 09:42 AM CDT

CTFA Responds to Lead in Lipstick Claim

CTFA has responded to the Campaign for Safe Cosmetics' claim that detectable levels of lead were found in mass market lipsticks...

Oct 12, 2007 | 09:31 AM CDT

Consumer Group Reports Traces of Lead in Lipstick

A consumer group has reported that a large number of lipsticks manufactured in the United States contain high levels of lead.

Sep 11, 2007 | 04:14 PM CDT

FDA Issues Warning Letter for Injectable Tan Product

The US Food and Drug Administration (FDA) has issued a warning letter to Melanocorp Inc. concerning the sale and marketing of the product Melanotan II.